An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation
Crossref DOI link: https://doi.org/10.1186/2047-1440-3-12
Published Online: 2014-06-13
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ekberg, Jana
Ekberg, Henrik
Jespersen, Bente
Källen, Ragnar
Skov, Karin
Olausson, Michael
Mjörnstedt, Lars
Lindnér, Per
Article History
Received: 11 March 2014
Accepted: 5 June 2014
First Online: 13 June 2014